BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 24211610)

  • 21. Single time point immune function assay (ImmuKnow) testing does not aid in the prediction of future opportunistic infections or acute rejection.
    Huskey J; Gralla J; Wiseman AC
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):423-9. PubMed ID: 21088287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of clinical association and effect of peripheral WBC counts on immune cell function test in kidney transplant recipients with T-cell depleting induction and steroid-sparing maintenance therapy.
    Sageshima J; Ciancio G; Chen L; Dohi T; El-Hinnawi A; Paloyo S; Gaynor JJ; Mattiazzi A; Guerra G; Kupin W; Roth D; Ruiz P; Burke GW
    Transpl Immunol; 2014 Mar; 30(2-3):88-92. PubMed ID: 24518158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocytes.
    Kobashigawa JA; Kiyosaki KK; Patel JK; Kittleson MM; Kubak BM; Davis SN; Kawano MA; Ardehali AA
    J Heart Lung Transplant; 2010 May; 29(5):504-8. PubMed ID: 20133166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring cellular immune function of renal transplant recipients based on adenosine triphosphate (ATP) production by mitogen-induced CD4+ T helper cells.
    Naderi H; Pourmand G; Dehghani S; Nikoueinejad H; Jafari M; Tajik N
    Biomed Pharmacother; 2018 Nov; 107():1402-1409. PubMed ID: 30257356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Individualized immune monitoring of cardiac transplant recipients by noninvasive longitudinal cellular immunity tests.
    Israeli M; Ben-Gal T; Yaari V; Valdman A; Matz I; Medalion B; Battler A; Sredni B; Kristt D; Klein T
    Transplantation; 2010 Apr; 89(8):968-76. PubMed ID: 20075792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of an immune cell function assay to differentiate rejection from infectious enteritis in pediatric intestinal transplant recipients.
    Wozniak LJ; Venick RS; Gordon Burroughs S; Ngo KD; Duffy JP; Farmer DG
    Clin Transplant; 2014 Feb; 28(2):229-35. PubMed ID: 24433466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical utility of CD4+ function assessment (ViraCor-IBT ImmuKnow test) in lung recipients.
    Piloni D; Magni S; Oggionni T; Benazzo A; Stella G; Scudeller L; Morosini M; Cova E; Meloni F
    Transpl Immunol; 2016 Jul; 37():35-39. PubMed ID: 27095000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is the intracellular ATP concentration of CD4+ T-Cells a predictive biomarker of immune status in stable transplant recipients?
    Millán O; Sánchez-Fueyo A; Rimola A; Guillen D; Hidalgo S; Benitez C; Campistol JM; Brunet M
    Transplantation; 2009 Aug; 88(3 Suppl):S78-84. PubMed ID: 19667966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-transplant immune state defined by serum markers and alloreactivity predicts acute rejection after living donor kidney transplantation.
    Vondran FW; Timrott K; Kollrich S; Steinhoff AK; Kaltenborn A; Schrem H; Klempnauer J; Lehner F; Schwinzer R
    Clin Transplant; 2014 Sep; 28(9):968-79. PubMed ID: 24931031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of several functional methods to evaluate the immune response on stable kidney transplant patients.
    Martínez-Flores JA; Serrano M; Morales P; Paz-Artal E; Morales JM; Serrano A
    J Immunol Methods; 2014 Jan; 403(1-2):62-5. PubMed ID: 24291342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of intercurrent EBV infection on ATP levels in CD4+ T cells of pediatric kidney transplant recipients.
    Ben-Youssef R; Baron PW; Sahney S; Weissman J; Baqai W; Franco E; Kore A; Trimzi M; Ojogho O
    Pediatr Transplant; 2009 Nov; 13(7):851-5. PubMed ID: 19017293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of immune cell function monitoring in renal transplantation after Thymoglobulin induction therapy.
    Serban G; Whittaker V; Fan J; Liu Z; Manga K; Khan M; Kontogianni K; Padmanabhan A; Cohen D; Suciu-Foca N; Ratner L; Colovai AI
    Hum Immunol; 2009 Nov; 70(11):882-90. PubMed ID: 19664673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation.
    Hashimoto K; Miller C; Hirose K; Diago T; Aucejo F; Quintini C; Eghtesad B; Corey R; Yerian L; Lopez R; Zein N; Fung J
    Clin Transplant; 2010; 24(5):701-8. PubMed ID: 20047619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preceeding the rejection: in search for a comprehensive post-transplant immune monitoring platform.
    Israeli M; Yussim A; Mor E; Sredni B; Klein T
    Transpl Immunol; 2007 Jul; 18(1):7-12. PubMed ID: 17584596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation Between Immunosuppressive Therapy and CD4(+) T-Cell Intracellular Adenosine Triphosphate Levels in Liver Transplant Recipients.
    Qu W; Zhu ZJ; Sun LY; Wei L; Liu Y; Zeng ZG
    Transplant Proc; 2016; 48(6):2094-7. PubMed ID: 27569951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
    Kuypers DR; Vanrenterghem Y
    Clin Ther; 2004 Nov; 26(11):1834-44. PubMed ID: 15639695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients.
    Cheung CY; Wong KM; Chan HW; Liu YL; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Li CS
    Transpl Int; 2006 Aug; 19(8):657-66. PubMed ID: 16827683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial.
    Ravaioli M; Neri F; Lazzarotto T; Bertuzzo VR; Di Gioia P; Stacchini G; Morelli MC; Ercolani G; Cescon M; Chiereghin A; Del Gaudio M; Cucchetti A; Pinna AD
    Transplantation; 2015 Aug; 99(8):1625-32. PubMed ID: 25757214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune cell function assay does not identify biopsy-proven pediatric renal allograft rejection or infection.
    Ryan CM; Chaudhuri A; Concepcion W; Grimm PC
    Pediatr Transplant; 2014 Aug; 18(5):446-52. PubMed ID: 24930482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of early rapid corticosteroid reduction on cell-mediated immunity in kidney transplant recipients.
    Li S; Wang W; Hu X; Ren L; Yin H; Yang X; Liu H; Zhang X
    Transpl Immunol; 2011 Jan; 24(2):127-30. PubMed ID: 20888912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.